Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 201 views

    Hydralazine Drug Study

    Uploaded by

    Sabrina Mascardo
    The document contains information about the drug hydralazine HCl including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Hydralazine HCl is a peripheral vasodilator that acts on vascular smooth muscle to cause vasodilation and lower blood pressure. It is indicated for the treatment of hypertension, both orally and parenterally. Adverse effects include headaches, dizziness, palpitations, and nausea. Nurses are responsible for monitoring the patient's blood pressure before and after administration and watching for adverse effects.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Hydralazine Drug Study

    Uploaded by

    Sabrina Mascardo
    201 views1 page
    The document contains information about the drug hydralazine HCl including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Hydralazine HCl is a peripheral vasodilator that acts on vascular smooth muscle to cause vasodilation and lower blood pressure. It is indicated for the treatment of hypertension, both orally and parenterally. Adverse effects include headaches, dizziness, palpitations, and nausea. Nurses are responsible for monitoring the patient's blood pressure before and after administration and watching for adverse effects.

    Original Title

    264889182-Hydralazine-Drug-Study

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document contains information about the drug hydralazine HCl including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Hydralazine HCl is a peripheral vasodilator that acts on vascular smooth muscle to cause vasodilation and lower blood pressure. It is indicated for the treatment of hypertension, both orally and parenterally. Adverse effects include headaches, dizziness, palpitations, and nausea. Nurses are responsible for monitoring the patient's blood pressure before and after administration and watching for adverse effects.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    201 views1 page

    Hydralazine Drug Study

    Uploaded by

    Sabrina Mascardo
    The document contains information about the drug hydralazine HCl including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. Hydralazine HCl is a peripheral vasodilator that acts on vascular smooth muscle to cause vasodilation and lower blood pressure. It is indicated for the treatment of hypertension, both orally and parenterally. Adverse effects include headaches, dizziness, palpitations, and nausea. Nurses are responsible for monitoring the patient's blood pressure before and after administration and watching for adverse effects.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Name of Patient F. S. Age 35 y.

    o Height 5’3
    Diagnosis G3P3 (3003) PU del. ceph. term live birth by 1oLSTCS + Sex Female Weight 60 kg
    BTL w/ variable deaceration; severe preeclampsia
    Author M. M. Olmillo Website milkv.co.vu A/N you’re welcome J
    NURSING
    MECHANISM OF CONTRAINDICATI ADVERSE
    DRUG DATA CLASSIFICATION ACTION
    INDICATIONS RESPONSIBILITIE
    ON EFFECTS
    S
    Generic Name: Pharmacologic: Acts directly on General: Contraindicated with CNS: headace, Before:
    Hydralazine Hcl Peripheral vascular smooth > oral: essential hypersensitivity to peripheral neuritis, > check doctor’s order
    vasodilator muscle to cause hypertension hydralazine, tartrazine; dizziness > wash hands before administering
    vasodilation, primarily alone or in CAD, mitral valvular the drug
    Trade name/s: arteriolar, decreasing combination with rheumatic heart disease CV: palpitations, > take the client’s BP
    Apresoline peripheral resistance; other drugs (implicated in MI) tachycardia, > check the patency of the IV line
    maintains or increases > parenteral: angina pectoris > educate the client about the
    renal and cerebral severe essential purpose and importance of the drug
    Patient’s dose: blood flow hypertension GI: anorexia,
    50mg q15mins. x Therapeutic: when drug cannot Precaution: nausea, vomiting,
    2 doses for BP Antihypertensive be given orally or Use cautiously with diarrhea
    ≥ 140/100
    when need to CVAs, increased ICP, During:
    lower BP is urgent severe hypertension with GU: difficult > Give drug exactly as prescribed
    >unlabeled uses: uremia, advanced renal micturation, > Take with food
    reducing afterload damage, lactation, impotence > discontinue if blood dyscrasias
    Maximum dose: Onset: in the treatment of pregnancy, pulmonary > withdraw drug gradually and not at
    800mg repeated Pregnancy Category Rapid heart failure, hypertension Hematologic: blood once
    as necessary Risk: C severe aortic dyscrasias > repeat the purpose of the drug
    Peak: insufficiency, and
    10-20mins after valve Hypersensitivity:
    Minimum dose: replacement rash, urticaria,
    5-10mg Duration: (doses up to pruritus After:
    2-4 hrs 800mg TID) Interactions: > Monitor client for orthostatic
    > drug-drug: increased hypertension
    Available forms: Metabolism: pharmacologic effect of Other: nasal > reevaluate therapy if patient
    Tablets – 10, 25, Hepatic, 3-7 hr beta-adrenergic blockers congestion, develops arthralgia, fever, chest pain,
    50, 100mg; Patient’s actual > drug-food: increased flushing, edema, or continued malaise.
    injection – Distribution: crosses indication: bioavailability of oral muscle cramps > report persistent or severe
    20mg/mL placenta, may enter Pregnancy- hydralazine given with constipation
    breast milk induced food > report unexplained fever or
    hypertension malaise, muscle or joint aching, rash,
    Route: IVTT Excretion: urine numbness, tingling
    > document and record.

    Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Lippincott’s Nursing
    Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Drug Guide

    You might also like